| Trimi Health | 79.0 | 3 | 2 |
| Cora Health | 68.3 | 2 | 2 |
| Mayo Clinic | 60.0 | 4 | 0 |
| National Institute for Occupational Safety and Health | 51.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 51.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 51.7 | 3 | 0 |
| Carl T. Hayden Veterans Affairs Medical Center | 51.7 | 3 | 0 |
| Office of Readiness and Response | 51.7 | 3 | 0 |
| WW International | 43.1 | 1 | 1 |
| Obesity Medicine Association | 43.1 | 1 | 1 |
| Noom | 43.1 | 1 | 1 |
| Profile Plan | 43.1 | 1 | 1 |
| Massachusetts General Hospital | 41.0 | 2 | 0 |
| United States Department of Veterans Affairs | 41.0 | 2 | 0 |
| Yale School of Medicine | 41.0 | 2 | 0 |
| Epi Info | 41.0 | 2 | 0 |
| Cleveland Clinic | 41.0 | 2 | 0 |
| Center for Drug Evaluation and Research | 41.0 | 2 | 0 |
| Everyday Health | 41.0 | 2 | 0 |
| Henry Ford Health | 41.0 | 2 | 0 |
| Northwell Health | 41.0 | 2 | 0 |
| Preventing Chronic Disease | 41.0 | 2 | 0 |
| Trustpilot | 41.0 | 2 | 0 |
| National Survey of Family Growth | 41.0 | 2 | 0 |
| National Vital Statistics System | 41.0 | 2 | 0 |
| NIOSH Power Tools Database | 41.0 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 41.0 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 41.0 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 41.0 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 41.0 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 41.0 | 2 | 0 |
| Journal of healthcare information management : JHIM | 41.0 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 41.0 | 2 | 0 |
| NCHS data brief | 41.0 | 2 | 0 |
| MMWR supplements | 41.0 | 2 | 0 |
| Forbes 30 Under 30 | 41.0 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 41.0 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 41.0 | 2 | 0 |
| VA Ann Arbor Healthcare System | 41.0 | 2 | 0 |
| Mayo Clinic Health System | 41.0 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 41.0 | 2 | 0 |
| Optum | 41.0 | 2 | 0 |
| Susan Shur-Fen Gau | 41.0 | 2 | 0 |
| Syosset Hospital | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| Christopher R. Conley | 41.0 | 2 | 0 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 41.0 | 2 | 0 |
| Healthcare Infection Control Practices Advisory Committee | 41.0 | 2 | 0 |
| Forbes ASAP | 41.0 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 41.0 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 41.0 | 2 | 0 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 41.0 | 2 | 0 |
| Juniper (telehealth company) | 40.0 | 0 | 4 |
| The Washington Post | 34.5 | 0 | 3 |
| JAMA Surgery | 34.5 | 0 | 3 |
| Rubrik | 34.5 | 0 | 3 |
| medical guideline | 27.3 | 0 | 2 |
| anti-obesity medication | 27.3 | 0 | 2 |
| Jenny Craig, Inc. | 27.3 | 0 | 2 |
| Weight loss camp | 27.3 | 0 | 2 |
| The effects of two workplace weight management programs and weight loss on health care utilization and costs | 27.3 | 0 | 2 |
| Through Thick and Thin: Identifying Barriers to Bariatric Surgery, Weight Loss Maintenance, and Tailoring Obesity Treatment for the Future | 27.3 | 0 | 2 |
| Where are family theories in family-based obesity treatment?: conceptualizing the study of families in pediatric weight management | 27.3 | 0 | 2 |
| Barriers to and Facilitators of Long Term Weight Loss Maintenance in Adult UK People: A Thematic Analysis | 27.3 | 0 | 2 |
| Designing Ontology-based Patterns for the Representation of the Time-Relevant Eligibility Criteria of Clinical Protocols | 27.3 | 0 | 2 |
| A systematic review of medicinal plants used for weight loss in Brazil: Is there potential for obesity treatment? | 27.3 | 0 | 2 |
| Insights from the POWER practice-based weight loss trial: a focus group study on the PCP's role in weight management | 27.3 | 0 | 2 |
| The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss | 27.3 | 0 | 2 |
| Equivalent weight loss for weight management programs delivered by phone and clinic | 27.3 | 0 | 2 |
| Weight loss surgery eligibility according to various BMI criteria among adolescents | 27.3 | 0 | 2 |
| The Most Popular Smartphone Apps for Weight Loss: A Quality Assessment | 27.3 | 0 | 2 |
| Effectiveness of a new dietetic weight management food to achieve weight loss in client-owned obese cats | 27.3 | 0 | 2 |
| Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss? | 27.3 | 0 | 2 |
| PDA+: A Personal Digital Assistant for Obesity Treatment - an RCT testing the use of technology to enhance weight loss treatment for veterans | 27.3 | 0 | 2 |
| The application of the glycemic index and glycemic load in weight loss: A review of the clinical evidence | 27.3 | 0 | 2 |
| Should providers encourage realistic weight expectations and satisfaction with lost weight in commercial weight loss programs? a preliminary study | 27.3 | 0 | 2 |
| Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. | 27.3 | 0 | 2 |
| Effect of a 12-week weight management program on the clinical characteristics and dietary intake of the young obese and the contributing factors to the successful weight loss | 27.3 | 0 | 2 |
| Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. | 27.3 | 0 | 2 |
| Shaking Up the System: The Role of Change in Maternal-Adolescent Communication Quality and Adolescent Weight Loss | 27.3 | 0 | 2 |
| Demographic profile, clinical characteristics, motivations and weight loss outcomes of patients in a nonsurgical weight management programme | 27.3 | 0 | 2 |
| Social embeddedness in an online weight management programme is linked to greater weight loss. | 27.3 | 0 | 2 |
| Adoption of the children's obesity clinic's treatment (TCOCT) protocol into another Danish pediatric obesity treatment clinic | 27.3 | 0 | 2 |
| Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic | 27.3 | 0 | 2 |
| Using personality as a predictor of diet induced weight loss and weight management | 27.3 | 0 | 2 |
| Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study | 27.3 | 0 | 2 |
| A qualitative study exploring why adults with intellectual disabilities and obesity want to lose weight and views of their carers | 27.3 | 0 | 2 |
| Impact of Registered Dietitian Expertise in Health Guidance for Weight Loss. | 27.3 | 0 | 2 |
| Best practice guidelines on informed consent for weight loss surgery patients | 27.3 | 0 | 2 |
| Safety and efficacy of a side-to-side duodeno-ileal anastomosis for weight loss and type-2 diabetes: duodenal bipartition, a novel metabolic surgery procedure | 27.3 | 0 | 2 |
| A review: which dietary plan is best for your patients seeking weight loss and sustained weight management? | 27.3 | 0 | 2 |
| The Influence of Sleep Disordered Breathing on Weight Loss in a National Weight Management Program | 27.3 | 0 | 2 |
| Anti-obesity medication use in adolescents: risks and benefits. | 27.3 | 0 | 2 |
| Changes in Weight Loss, Health Behaviors, and Intentions among 400 Participants Who Dropped out from an Insurance-Sponsored, Community-Based Weight Management Program | 27.3 | 0 | 2 |
| The association between rate of initial weight loss and long-term success in obesity treatment: does slow and steady win the race? | 27.3 | 0 | 2 |
| Relationship of food addiction to weight loss and attrition during obesity treatment. | 27.3 | 0 | 2 |
| A method for probing disease relatedness using common clinical eligibility criteria | 27.3 | 0 | 2 |
| Informed consent for mammography screening: modelling the risks and benefits for American women. | 27.3 | 0 | 2 |
| Evaluation of attendance and weight loss in an intensive weight management clinic compared to standard dietetic care | 27.3 | 0 | 2 |
| Setting targets leads to greater long-term weight losses and 'unrealistic' targets increase the effect in a large community-based commercial weight management group | 27.3 | 0 | 2 |
| Adherence and weight loss outcomes associated with food-exercise diary preference in a military weight management program | 27.3 | 0 | 2 |
| Respiratory clinical guidelines inform ward-based nurses' clinical skills and knowledge required for evidence-based care | 27.3 | 0 | 2 |
| Proposed role of calcium and dairy food components in weight management and metabolic health | 27.3 | 0 | 2 |
| Predictors of weight loss maintenance following an insurance-sponsored weight management program | 27.3 | 0 | 2 |
| Exercise, appetite and weight management: understanding the compensatory responses in eating behaviour and how they contribute to variability in exercise-induced weight loss | 27.3 | 0 | 2 |
| Gingival recession and adult orthodontics: a clinical evidence-based treatment proposal | 27.3 | 0 | 2 |
| Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits | 27.3 | 0 | 2 |
| Risks and Benefits of Weight Loss in Heart Failure | 27.3 | 0 | 2 |
| Extremes of weight gain and weight loss with detailed assessments of energy balance: Illustrative case studies and clinical recommendations | 27.3 | 0 | 2 |
| The core clinical protocol ontology (C2PO): A realist ontology for representing the recommendations within clinical guidelines | 27.3 | 0 | 2 |
| Effects of meal frequency on weight loss and body composition: a meta-analysis | 27.3 | 0 | 2 |
| Weight management practices and evidence for weight loss through primary care: a brief review | 27.3 | 0 | 2 |
| A Novel Clinical Protocol for Placement and Management of Indwelling Urinary Catheters in Older Adults in the Emergency Department | 27.3 | 0 | 2 |
| Evidence-based clinical guidelines in Kyrgyz Republic | 27.3 | 0 | 2 |
| Is Endoluminal Bariatric Therapy a New Paradigm of Treatment for Obesity? | 27.3 | 0 | 2 |
| Obesity Treatment at HealthPartners: Adaptation of Clinical Guidelines into Systems for Practice Operations | 27.3 | 0 | 2 |
| Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors | 27.3 | 0 | 2 |
| The future of obesity treatment: comment on "Integrating technology into standard weight loss treatment: a randomized controlled trial". | 27.3 | 0 | 2 |
| Sex Differences in Weight Loss among Veterans with Serious Mental Illness: Observational Study of a National Weight Management Program. | 27.3 | 0 | 2 |
| Best practice updates for informed consent and patient education in weight loss surgery | 27.3 | 0 | 2 |
| Sex differences in the relation of weight loss self-efficacy, binge eating, and depressive symptoms to weight loss success in a residential obesity treatment program | 27.3 | 0 | 2 |
| Veterans with PTSD report more weight loss barriers than Veterans with no mental health disorders | 27.3 | 0 | 2 |
| Transformative Lifestyle Change: key to sustainable weight loss among women in a post‐partum diet and exercise intervention | 27.3 | 0 | 2 |
| Early treatment response as a predictor of ongoing weight loss in obesity treatment. | 27.3 | 0 | 2 |
| Dual Intragastric Balloon: Single Ambulatory Center Spanish Experience with 60 Patients in Endoscopic Weight Loss Management | 27.3 | 0 | 2 |
| The role of physicians in promoting weight loss | 27.3 | 0 | 2 |
| Difference in weight loss based on ethnicity, age and comorbidity status in a publicly funded adult weight management centre: 1‐year results | 27.3 | 0 | 2 |
| Meal replacements as a weight loss tool in a population with severe mental illness | 27.3 | 0 | 2 |
| Communicating Risks and Benefits in Informed Consent for Research: A Qualitative Study. | 27.3 | 0 | 2 |
| Clinical protocols: the next automation frontier. Computerized records will play a key role in the implementation of clinical guidelines. | 27.3 | 0 | 2 |
| “That's who I am: A fat person in a thin body”: Weight loss, negative self-evaluation, and mitigating strategies following weight loss surgery | 27.3 | 0 | 2 |
| Diet Quality of Breast Cancer Survivors after a Six-Month Weight Management Intervention: Improvements and Association with Weight Loss | 27.3 | 0 | 2 |
| Effects of a community-based weight loss program, jointly established by local government and university faculty, on weight loss and metabolic syndrome components: the Sodegaura Weight Management Study | 27.3 | 0 | 2 |
| Informed consent: are researchers accurately representing risks and benefits? | 27.3 | 0 | 2 |
| Impacts of Efficacy and Exemplification in an Online Message About Weight Loss on Weight Management Self-Efficacy, Satisfaction, and Personal Importance | 27.3 | 0 | 2 |
| Predictors of clinically significant weight loss and participant retention in an insurance-sponsored community-based weight management program | 27.3 | 0 | 2 |
| Patient predictors of weight loss following a behavioral weight management intervention among US Veterans with severe obesity. | 27.3 | 0 | 2 |
| Weight loss after participation in a national VA weight management program among veterans with or without PTSD. | 27.3 | 0 | 2 |
| Does adherence to a motivational counseling program impact weight loss? | 27.3 | 0 | 2 |
| Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth? | 27.3 | 0 | 2 |
| Impact of an Emergency Department–Initiated Clinical Protocol for the Evaluation and Treatment of Atrial Fibrillation | 27.3 | 0 | 2 |
| Understanding the relationship between weight loss, emotional well-being and health-related quality of life in patients attending a specialist obesity weight management service | 27.3 | 0 | 2 |
| Efficacy of healthy weight loss program in obesity treatment: Croatian experience | 27.3 | 0 | 2 |
| Changes in serum leptin and beta endorphin levels with weight loss by electroacupuncture and diet restriction in obesity treatment | 27.3 | 0 | 2 |
| A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease | 27.3 | 0 | 2 |
| Erratum to: Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss? | 27.3 | 0 | 2 |
| Weight loss and frequency of body-weight self-monitoring in an online commercial weight management program with and without a cellular-connected 'smart' scale: a randomized pilot study | 27.3 | 0 | 2 |
| Knowledge of appropriate foods and beverages needed for weight loss and diet of patients in an Obesity Clinic. | 27.3 | 0 | 2 |
| Characterizing the Pattern of Weight Loss and Regain in Adults Enrolled in a 12-Week Internet-Based Weight Management Program | 27.3 | 0 | 2 |
| The effect of impaired glucose metabolism on weight loss in multidisciplinary childhood obesity treatment. | 27.3 | 0 | 2 |
| Maintenance of weight loss after obesity treatment: is continuous support necessary? | 27.3 | 0 | 2 |
| The effects of multi-component weight management interventions on weight loss in adults with intellectual disabilities and obesity: A systematic review and meta-analysis of randomised controlled trials | 27.3 | 0 | 2 |
| Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis. | 27.3 | 0 | 2 |
| Weight management and weight loss strategies of professional jockeys | 27.3 | 0 | 2 |
| Greater history of weight-related stigmatizing experience is associated with greater weight loss in obesity treatment | 27.3 | 0 | 2 |
| Medical Devices; Gastroenterology-Urology Devices; Classification of the Oral Removable Palatal Space Occupying Device for Weight Management and/or Weight Loss. Final order | 27.3 | 0 | 2 |
| US Registered Dietitian Nutritionists' Knowledge and Attitudes of Intuitive Eating and Use of Various Weight Management Practices | 27.3 | 0 | 2 |
| Childhood obesity treatment: telephone coaching is as good as usual care in maintaining weight loss - a randomized controlled trial. | 27.3 | 0 | 2 |
| Psychological disorder, symptom severity and weight loss in inpatient adolescent obesity treatment | 27.3 | 0 | 2 |
| Is There an Optimal Diet for Weight Management and Metabolic Health? | 27.3 | 0 | 2 |
| Task-based weight management programme delivered in primary care promotes better long-term weight loss among women from lower socioeconomic groups than usual practice. | 27.3 | 0 | 2 |
| Effects of breakfast eating and eating frequency on body mass index and weight loss outcomes in adults enrolled in an obesity treatment program | 27.3 | 0 | 2 |
| What Strategies do Registered Dietitian Nutritionists Use to Assess a Patient's/Client's Weight Loss Readiness? | 27.3 | 0 | 2 |
| Are smaller weight losses or more achievable weight loss goals better in the long term for obese patients? | 27.3 | 0 | 2 |
| Do more specific plans help you lose weight? Examining the relationship between plan specificity, weight loss goals, and plan content in the context of a weight management programme. | 27.3 | 0 | 2 |
| Physical activity affects weight loss and weight management | 27.3 | 0 | 2 |
| Use of a weight loss index for evaluating weight management in adults | 27.3 | 0 | 2 |
| Self-efficacy, attendance, and weight loss in obesity treatment. | 27.3 | 0 | 2 |
| What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes | 27.3 | 0 | 2 |
| Weight loss strategies for obese adults: personalized weight management program vs. standard care | 27.3 | 0 | 2 |
| Attrition and weight loss outcomes for patients with complex obesity, anxiety and depression attending a weight management programme with targeted psychological treatment | 27.3 | 0 | 2 |
| Weight management issues and strategies for people with high cardiovascular risk undertaking an Australian weight loss program: A focus group study | 27.3 | 0 | 2 |
| Do feeding practices of obese dogs, before weight loss, affect the success of weight management? | 27.3 | 0 | 2 |
| Patient characteristics as predictors of weight loss after an obesity treatment for children | 27.3 | 0 | 2 |
| Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program | 27.3 | 0 | 2 |
| A preliminary investigation into whether early intervention can improve weight loss among those initially non-responsive to an internet-based behavioral program | 27.3 | 0 | 2 |
| Psycho-markers of weight loss. The roles of TFEQ Disinhibition and Restraint in exercise-induced weight management | 27.3 | 0 | 2 |
| Weight loss and improved gross motor coordination in children as a result of multidisciplinary residential obesity treatment | 27.3 | 0 | 2 |
| Participation as a leader in immersion weight loss treatment may benefit, not harm, young adult staff members | 27.3 | 0 | 2 |
| Clinical guidelines for weight management in New Zealand adults, children and young people | 27.3 | 0 | 2 |
| Direct observation of weight counselling in primary care: alignment with clinical guidelines | 27.3 | 0 | 2 |
| Academy of Nutrition and Dietetics: Standards of Practice and Standards of Professional Performance for Registered Dietitian Nutritionists (Competent, Proficient, and Expert) in Adult Weight Management | 27.3 | 0 | 2 |
| The effect of psychiatric disorders on weight loss in obesity clinic patients | 27.3 | 0 | 2 |
| Rorschach personality predictors of weight loss with behavior modification in obesity treatment | 27.3 | 0 | 2 |
| Modest weight loss through a 12-week weight management program with behavioral modification seems to attenuate inflammatory responses in young obese Koreans. | 27.3 | 0 | 2 |
| The effect of rate of weight loss on long-term weight management: a randomised controlled trial. | 27.3 | 0 | 2 |
| The Use of Technology for Delivering a Weight Loss Program for Adolescents with Intellectual and Developmental Disabilities | 27.3 | 0 | 2 |
| The Eating Disorder Inventory in a UK National Health Service Obesity Clinic and its response to modest weight loss | 27.3 | 0 | 2 |
| Change in body image and psychological well-being during behavioral obesity treatment: Associations with weight loss and maintenance. | 27.3 | 0 | 2 |
| Factors predictive of drop‐out and weight loss success in weight management of obese patients | 27.3 | 0 | 2 |
| Gender differences in weight loss; evidence from a NHS weight management service. | 27.3 | 0 | 2 |
| Initial weight loss is the best predictor for success in obesity treatment and sociodemographic liabilities increase risk for drop-out | 27.3 | 0 | 2 |
| Informed Consent in Pediatric Otolaryngology: What Risks and Benefits Do Parents Recall? | 27.3 | 0 | 2 |
| Psychosocial factors and perspectives on weight gain and barriers to weight loss among adolescents enrolled in obesity treatment | 27.3 | 0 | 2 |
| Long-Term Weight Loss Effects of a Behavioral Weight Management Program: Does the Community Food Environment Matter? | 27.3 | 0 | 2 |
| An Evidence-Based Protocol for Antibiotic Use Prior to Cystoscopy Decreases Antibiotic Use without Impacting Post-Procedural Symptomatic Urinary Tract Infection Rates | 27.3 | 0 | 2 |
| Dental ethics case. 3: Informed consent: risks and benefits of treatment | 27.3 | 0 | 2 |
| Follow-up Care for Survivors of Prostate Cancer - Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline | 27.3 | 0 | 2 |
| Parents' informed consent decisions regarding psychotherapy for their children: Consideration of therapeutic risks and benefits | 27.3 | 0 | 2 |
| Continuity of care, informed consent, and fiduciary responsibilities in for-profit managed care systems | 27.3 | 0 | 2 |
| Vaccination Informed Consent Ontology | 27.3 | 0 | 2 |
| Long-term weight loss trajectories following participation in a randomised controlled trial of a weight management programme for men delivered through professional football clubs: a longitudinal cohort study and economic evaluation. | 27.3 | 0 | 2 |
| Response to "Informed Consent in Pediatric Otolaryngology: What Risks and Benefits Do Parents Recall?" | 27.3 | 0 | 2 |
| In Reference to "Informed Consent in Pediatric Otolaryngology: What Risks and Benefits Do Parents Recall?" | 27.3 | 0 | 2 |
| The risks and benefits of disclosing psychotherapy records to the legal system: What psychologists and patients need to know for informed consent | 27.3 | 0 | 2 |
| Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study | 27.3 | 0 | 2 |
| Informed consent to immunization: the risks and benefits of individual autonomy | 27.3 | 0 | 2 |
| Beyond weight loss: A qualitative exploration of participant expectations and strategies for measuring progress during a weight management program | 27.3 | 0 | 2 |
| Review of the Clinical Evidence on Tea Consumption and Weight Loss | 27.3 | 0 | 2 |
| "Last Supper" Predicts Greater Weight Loss Early in Obesity Treatment, but Not Enough to Offset Initial Gains | 27.3 | 0 | 2 |
| Development of a scalable weight loss intervention for low-income workers through adaptation of interactive obesity treatment approach (iOTA) | 27.3 | 0 | 2 |
| Phone Versus Clinical Approach to Weight Loss | 27.3 | 0 | 2 |
| Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors | 27.3 | 0 | 2 |
| Risks and benefits of weight loss: challenges to obesity research | 27.3 | 0 | 2 |
| Using the Electronic Health Record to Guide Management of Newborn Weight Loss | 27.3 | 0 | 2 |
| Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service | 27.3 | 0 | 2 |
| Development and Pilot Testing of a Childhood Obesity Treatment Program | 27.3 | 0 | 2 |
| Progressive Weight Loss and Metabolic Health | 27.3 | 0 | 2 |
| CHRONOtype-adjusted DIET on Weight Loss | 27.3 | 0 | 2 |
| PACE CALL: Weight Loss Study for Childhood Leukemia Survivors | 27.3 | 0 | 2 |
| The Weight-Wise Weight Loss Translation Study | 27.3 | 0 | 2 |
| A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics | 27.3 | 0 | 2 |
| Lay Health Coaches for Weight Loss: Peers Versus Mentors | 27.3 | 0 | 2 |
| Effects of Re-Feeding Duration on Weight Maintenance After Weight Loss With Very-Low-Energy Diets (VLEDs) | 27.3 | 0 | 2 |
| Study Testing Patient Decision Tools Related to the Risks and Benefits of Weight Loss Surgery | 27.3 | 0 | 2 |
| Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes | 27.3 | 0 | 2 |
| Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults | 27.3 | 0 | 2 |
| Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health | 27.3 | 0 | 2 |
| Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health | 27.3 | 0 | 2 |
| HealthyMe Online Weight Management Education/HealthyMe at Home | 27.3 | 0 | 2 |
| STUDY: Effects of Potatoes in a Weight Loss Program | 27.3 | 0 | 2 |
| Think Health! A Personal Weight Management Program | 27.3 | 0 | 2 |
| GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children | 27.3 | 0 | 2 |
| Weight Loss for Uncontrolled Asthma Associated With Elevated BMI | 27.3 | 0 | 2 |
| Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers | 27.3 | 0 | 2 |
| Reducing Snack Variety in Weight Loss Treatment | 27.3 | 0 | 2 |
| W8Loss2Go: mHealth Weight Management Strategy | 27.3 | 0 | 2 |
| Can a Novel Treatment Using "Mandometer®" Technology Improve Weight Loss in a Childhood Obesity Clinic? | 27.3 | 0 | 2 |
| Internet Assisted Obesity Treatment | 27.3 | 0 | 2 |
| Impact of Protein Quantity Within the USDA Healthy Style Eating Pattern on Sleep | 27.3 | 0 | 2 |
| The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS | 27.3 | 0 | 2 |
| Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women | 27.3 | 0 | 2 |
| The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management | 27.3 | 0 | 2 |
| NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You | 27.3 | 0 | 2 |
| Impact of Mobile Phone Texting Service to Support Weight Loss | 27.3 | 0 | 2 |
| Weight Loss Physical Disabilities | 27.3 | 0 | 2 |
| Connect for Health Pediatric Weight Management Program | 27.3 | 0 | 2 |
| Childhood Obesity Treatment - Telephone Coaching vc Usual Care | 27.3 | 0 | 2 |
| Smart Technology for Weight Loss and Metabolic Health | 27.3 | 0 | 2 |
| CARE Trial: Comparing Different Levels of Calorie Reduction for Weight Loss | 27.3 | 0 | 2 |
| Predictors of successful weight loss in an outpatient obesity clinic | 27.3 | 0 | 2 |
| clinical protocol | 27.3 | 0 | 2 |
| Physical exercise for preventing obesity, promoting weight loss and maintaining weight management | 27.3 | 0 | 2 |
| Diet for the Maintenance of Weight Loss and Metabolic Health in Obese Postmenopausal Women | 27.3 | 0 | 2 |
| Engaging Patients in Weight Loss Tools | 27.3 | 0 | 2 |
| Weight loss can be as simple as 10, 20, 30--Knoll launches blueprint for the use of sibutramine in weight management | 27.3 | 0 | 2 |
| Informed consent for body contouring procedures in the massive weight loss patient | 27.3 | 0 | 2 |
| CBT for obesity treatment in primary health care. Randomized trials show good weight loss 1,5 year following treatment | 27.3 | 0 | 2 |
| Motivation, behavior change, and weight management. Motivation-enforced weight loss programs conducted via the Internet may be the silver bullet for the nation's obesity epidemic | 27.3 | 0 | 2 |
| 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline for the Management of Overweight and Obesity in Adults: Implications and New Opportunities for Registered Dietitian Nutritionists | 27.3 | 0 | 2 |
| GLP-1 agonist supports weight loss | 27.3 | 0 | 2 |
| Intensive weight management in primary care improved weight loss and remission of type 2 diabetes | 27.3 | 0 | 2 |
| Cardiovascular Risks and Benefits of Medications Used for Weight Loss | 27.3 | 0 | 2 |
| DIAL now protocol: A randomized trial examining the provision of phone coaching to those with sub-optimal early weight loss during an Internet weight management program | 27.3 | 0 | 2 |
| Setting realistic expectations for weight loss after laparoscopic sleeve gastrectomy | 27.3 | 0 | 2 |
| Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial | 27.3 | 0 | 2 |
| The Cambridge Intensive Weight Management Programme Appears to Promote Weight Loss and Reduce the Need for Bariatric Surgery in Obese Adults | 27.3 | 0 | 2 |
| Liraglutide, GLP-1 receptor agonist, for chronic weight loss | 27.3 | 0 | 2 |
| Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment | 27.3 | 0 | 2 |
| Obesity Treatment: A Focus on Pharmacotherapy of Weight Management | 27.3 | 0 | 2 |
| Beyond weight loss: Impact of a weight management programme for mid-older Australians in private health insurance | 27.3 | 0 | 2 |
| Presence of CC Genotype for rs17773430 Could Affect the Percentage of Excess Weight Loss 1 Year After Bariatric Surgery: Tehran Obesity Treatment Study (TOTS) | 27.3 | 0 | 2 |
| Long-Term Weight Loss and Metabolic Health in Adults Concerned With Maintaining or Losing Weight: Findings From NHANES | 27.3 | 0 | 2 |
| Author Correction: Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial | 27.3 | 0 | 2 |
| Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet | 27.3 | 0 | 2 |
| Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme | 27.3 | 0 | 2 |
| Child and parent reports of children's depressive symptoms in relation to children's weight loss response in family-based obesity treatment | 27.3 | 0 | 2 |
| Do stress eating or compulsive eating influence metabolic health in a mindfulness-based weight loss intervention? | 27.3 | 0 | 2 |
| Fractures in Adults After Weight Loss from Bariatric Surgery and Weight Management Programs for Obesity: Systematic Review and Meta-analysis | 27.3 | 0 | 2 |
| The role of intermittent fasting and meal timing in weight management and metabolic health | 27.3 | 0 | 2 |
| Knowledge-based Dietary Weight Management. | 27.3 | 0 | 2 |
| Weight loss and BMI criteria in GLIM's definition of malnutrition is associated with postoperative complications following abdominal resections - Results from a National Quality Registry | 27.3 | 0 | 2 |
| Letter to the Editor Concerning: Fractures in Adults After Weight Loss from Bariatric Surgery and Weight Management Programs for Obesity: Systematic Review and Meta-analysis | 27.3 | 0 | 2 |
| Reassessing the risk of kidney organ donation: Researchers are taking a closer look at the long-term health risks that living kidney donors may face to refine the informed consent process and improve follow-up care | 27.3 | 0 | 2 |
| Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice | 27.3 | 0 | 2 |
| Provider Counseling and Weight Loss Outcomes in a Primary Care-Based Digital Obesity Treatment | 27.3 | 0 | 2 |
| Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity | 27.3 | 0 | 2 |
| In type 2 diabetes, a primary care-led weight management program increased weight loss and diabetes remission at 2 years | 27.3 | 0 | 2 |
| The Relationship Between Preoperative Kidney Function and Weight Loss After Bariatric Surgery in Patients with Estimated Glomerular Filtration Rate ≥ 30 mL/min: Tehran Obesity Treatment Study | 27.3 | 0 | 2 |
| Continuity of Care, Follow-Up Care, and Outcomes among Breast Cancer Survivors | 27.3 | 0 | 2 |
| Behavioral and Psychological Strategies of Long-Term Weight Loss Maintainers in a Widely Available Weight Management Program | 27.3 | 0 | 2 |
| SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management | 27.3 | 0 | 2 |
| WHO releases guidance on mental health care after trauma. New clinical protocol and guidelines to enable effective mental health care for adults and children exposed to trauma and loss | 27.3 | 0 | 2 |
| Obesity Treatment: A Focus on Pharmacotherapy of Weight Management: Erratum | 27.3 | 0 | 2 |
| Insurance-Mandated Medical Weight Management Programs in Sleeve Gastrectomy Patients Do Not Improve Postoperative Weight Loss Outcomes at 1 Year | 27.3 | 0 | 2 |
| Nondigestible Carbohydrates Affect Metabolic Health and Gut Microbiota in Overweight Adults after Weight Loss | 27.3 | 0 | 2 |
| Family Meal Practices and Weight Talk Between Adult Weight Management and Weight Loss Surgery Patients and Their Children | 27.3 | 0 | 2 |
| Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity | 27.3 | 0 | 2 |
| Emotion regulation strategies predict weight loss during an inpatient obesity treatment for adolescents | 27.3 | 0 | 2 |
| Group Education & Lifestyle Modification's Impact on Weight Loss & Quality Life of Patients With OA | 27.3 | 0 | 2 |
| Effect of Behavioral Weight Management Interventions Using Lifestyle mHealth Self-Monitoring on Weight Loss: A Systematic Review and Meta-Analysis | 27.3 | 0 | 2 |
| A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant | 27.3 | 0 | 2 |
| Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss | 27.3 | 0 | 2 |
| Barriers and facilitators of successful weight loss during participation in behavioural weight management programmes: a protocol for a systematic review | 27.3 | 0 | 2 |
| Weight loss during medical weight management does not predict weight loss after bariatric surgery: a retrospective cohort study | 27.3 | 0 | 2 |
| Class 3 Obesity in a Multidisciplinary Metabolic Weight Management Program: The Effect of Preexisting Type 2 Diabetes on 6-Month Weight Loss | 27.3 | 0 | 2 |
| [POST MASSIVE WEIGHT LOSS BODY CONTOURING SURGERIES CONTRIBUTE SIGNIFICANTLY TO OBESITY TREATMENT] | 27.3 | 0 | 2 |
| Comment on: Weight loss during medical weight management does not predict weight loss after bariatric surgery: a retrospective cohort study | 27.3 | 0 | 2 |
| Physicians certified by the American Board of Obesity Medicine provide evidence-based care | 27.3 | 0 | 2 |
| Web-based virtual reality to enhance behavioural skills training and weight loss in a commercial online weight management programme: The Experience Success randomized trial | 27.3 | 0 | 2 |
| A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults | 27.3 | 0 | 2 |
| tirzepatide | 27.3 | 0 | 2 |
| weight loss treatment | 27.3 | 0 | 2 |
| Informed Consent to Immunization: The Risks and Benefits of Individual Autonomy | 27.3 | 0 | 2 |
| "Tubby, like a marshmallow" : the lived experiences of children and their parents as participants in a child weight management programme | 27.3 | 0 | 2 |
| Use of a non-dieting approach to support weight management patients to improve eating behaviours and dietary intake | 27.3 | 0 | 2 |
| Evaluation of a weight management program using the intuitive eating approach for clinically overweight and obese adults | 27.3 | 0 | 2 |
| Novel Combination of Exercise and Carbohydrate Restriction for Metabolic Health | 27.3 | 0 | 2 |
| LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept | 27.3 | 0 | 2 |
| Self-Weighing for Adolescents Seeking Obesity Treatment | 27.3 | 0 | 2 |
| Selection of antiobesity medications based on phenotypes enhances weight loss: a pragmatic trial in an obesity clinic | 27.3 | 0 | 2 |
| Understanding Variability in Behavioral Weight Loss Treatment Response in Young Women (Ready SET Health) | 27.3 | 0 | 2 |
| A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland | 27.3 | 0 | 2 |
| Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity | 27.3 | 0 | 2 |
| Semaglutide Use in Elderly Obese Patients | 27.3 | 0 | 2 |
| The Niche of n-of-1 Trials in Precision Medicine for Weight Loss and Obesity Treatment: Back to the Future | 27.3 | 0 | 2 |
| Comparison of Weight Loss Between Consecutive Diabetic and Non-Diabetic Patients Enrolled in a Structured Weight Management Program—Data from the EMERALD Registry | 27.3 | 0 | 2 |
| eligibility criteria | 27.3 | 0 | 2 |
| Deborah B. Horn | 27.3 | 0 | 2 |
| Weight Management Strategies of Successful Weight Maintainers Subsequent to Clinically Relevant Weight Loss | 27.3 | 0 | 2 |
| Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved | 27.3 | 0 | 2 |
| Review on Predictors of Weight Loss Maintenance after Successful Weight Loss in Obesity Treatment | 27.3 | 0 | 2 |
| Efficacy of Liraglutide: GLP 1 Receptor Agonist on Glycemic Control and Weight Loss among Patients with Type 2 Diabetes | 27.3 | 0 | 2 |
| Evaluation of an NCCN guideline-based weight management pathway on weight loss in female breast cancer patients. | 27.3 | 0 | 2 |
| Risks and Benefits of Large Volume Paracentesis in Spontaneous Bacterial Peritonitis With Tense Ascites: Where is the Clinical Evidence? | 27.3 | 0 | 2 |
| 1124 Identifying Predictors of Weight Loss for Patients Enrolled in an Intensive Medical Weight Management Program | 27.3 | 0 | 2 |
| A 10-Week Pedometer-Based Walking Program Induced Weight Loss and Improved Metabolic Health in Community-Dwelling Adults | 27.3 | 0 | 2 |
| Registered Dietitian Nutritionists (RDN) in Corporate Wellness: A Valuable Effect on Metabolic Health and Lifestyle Habits | 27.3 | 0 | 2 |
| Predictors of weight loss in a Secondary Care Tier 3 Specialist Weight Management Service Following Modifications due to the COVID-19 Pandemic | 27.3 | 0 | 2 |
| Evaluation of a new causal chain model for predicting embedded psychosocial and behavioral relationships in a community‐based obesity treatment seeking maintained weight loss | 27.3 | 0 | 2 |
| Q135239885 | 27.3 | 0 | 2 |
| Q135970336 | 27.3 | 0 | 2 |
| Q136788425 | 27.3 | 0 | 2 |
| Weight Management Cooking: Healthy Recipes for Weight Loss | 27.3 | 0 | 2 |
| Go Leaner | 27.3 | 0 | 2 |
| Harbor | 27.3 | 0 | 2 |
| United States Food and Drug Administration | 25.8 | 1 | 0 |
| Q229883 | 25.8 | 1 | 0 |
| James Rothman | 25.8 | 1 | 0 |
| The World's Billionaires | 25.8 | 1 | 0 |
| United States Centers for Disease Control and Prevention | 25.8 | 1 | 0 |
| Eli Lilly and Company | 25.8 | 1 | 0 |
| Johns Hopkins School of Medicine | 25.8 | 1 | 0 |
| Slim Fast | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| The World's Most Powerful People | 25.8 | 1 | 0 |
| Forbes Global 2000 | 25.8 | 1 | 0 |
| Pennsylvania Hospital | 25.8 | 1 | 0 |
| Mike Lazaridis | 25.8 | 1 | 0 |
| National Taiwan University Hospital | 25.8 | 1 | 0 |
| Johns Hopkins Hospital | 25.8 | 1 | 0 |
| Walgreens | 25.8 | 1 | 0 |
| United States Secretary of Veterans Affairs | 25.8 | 1 | 0 |
| polymyalgia rheumatica | 25.8 | 1 | 0 |
| Morbidity and Mortality Weekly Report | 25.8 | 1 | 0 |
| CVS Pharmacy | 25.8 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 25.8 | 1 | 0 |
| Forbes 400 | 25.8 | 1 | 0 |
| Vattikuti Urology Institute | 25.8 | 1 | 0 |
| Henry Ford Hospital | 25.8 | 1 | 0 |
| National Center for Health Statistics | 25.8 | 1 | 0 |
| Advisory Committee on Immunization Practices | 25.8 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 25.8 | 1 | 0 |
| Henry Ford Jackson Hospital | 25.8 | 1 | 0 |
| Anne Schuchat | 25.8 | 1 | 0 |
| ArrayTrack | 25.8 | 1 | 0 |
| Bad Bug Book | 25.8 | 1 | 0 |
| Banner Health | 25.8 | 1 | 0 |
| Bath VA Medical Center | 25.8 | 1 | 0 |
| Center for Biologics Evaluation and Research | 25.8 | 1 | 0 |
| Center for Devices and Radiological Health | 25.8 | 1 | 0 |
| Center for Food Safety and Applied Nutrition | 25.8 | 1 | 0 |
| Center for Tobacco Products | 25.8 | 1 | 0 |
| Center for Veterinary Medicine | 25.8 | 1 | 0 |
| Chapter 1607 | 25.8 | 1 | 0 |
| Emerging Infectious Diseases | 25.8 | 1 | 0 |
| Donald Engelman | 25.8 | 1 | 0 |
| Doximity | 25.8 | 1 | 0 |
| Epi Map | 25.8 | 1 | 0 |
| Epidemic Intelligence Service | 25.8 | 1 | 0 |
| Fire Fighter Fatality Investigation and Prevention Program | 25.8 | 1 | 0 |
| Franciscan Skemp Medical Center | 25.8 | 1 | 0 |
| Gordon M. Shepherd | 25.8 | 1 | 0 |
| HealthPartners | 25.8 | 1 | 0 |
| Health Hazard Evaluation | 25.8 | 1 | 0 |
| Healthcare Information and Management Systems Society | 25.8 | 1 | 0 |
| Hospital of the University of Pennsylvania | 25.8 | 1 | 0 |
| Howard County General Hospital | 25.8 | 1 | 0 |
| Veterans Health Administration | 25.8 | 1 | 0 |
| Long Island Jewish Medical Center | 25.8 | 1 | 0 |
| MUSC Medical Center | 25.8 | 1 | 0 |
| Mayo Clinic Hospital – Jacksonville | 25.8 | 1 | 0 |
| Mayo School of Health Sciences | 25.8 | 1 | 0 |
| Nathaniel Raymond | 25.8 | 1 | 0 |
| National Center for Injury Prevention and Control | 25.8 | 1 | 0 |
| National Center for Toxicological Research | 25.8 | 1 | 0 |
| National Diabetes Education Program | 25.8 | 1 | 0 |
| National Health Interview Survey | 25.8 | 1 | 0 |
| Office of Criminal Investigations | 25.8 | 1 | 0 |
| Mass General Brigham | 25.8 | 1 | 0 |
| Penn Presbyterian Medical Center | 25.8 | 1 | 0 |
| Perelman Center for Advanced Medicine | 25.8 | 1 | 0 |
| Post-9/11 Veterans Educational Assistance Act of 2008 | 25.8 | 1 | 0 |
| Prime Healthcare Services | 25.8 | 1 | 0 |
| Public Health Information Network | 25.8 | 1 | 0 |
| ReachMD | 25.8 | 1 | 0 |
| Red Wing Medical Center | 25.8 | 1 | 0 |
| Scheie Eye Institute | 25.8 | 1 | 0 |
| Sibley Memorial Hospital | 25.8 | 1 | 0 |
| Sleep Research Society | 25.8 | 1 | 0 |
| Stanford Hospital and Clinics | 25.8 | 1 | 0 |
| Stanford University Medical Center | 25.8 | 1 | 0 |
| Tuskegee Veterans Administration Medical Center | 25.8 | 1 | 0 |
| UCSF Medical Center | 25.8 | 1 | 0 |
| University System of New Hampshire | 25.8 | 1 | 0 |
| Michigan Medicine | 25.8 | 1 | 0 |
| University of Pennsylvania Health System | 25.8 | 1 | 0 |
| VA Boston Healthcare System | 25.8 | 1 | 0 |
| VERB | 25.8 | 1 | 0 |
| Vaccines for Children Program | 25.8 | 1 | 0 |
| Victor Velculescu | 25.8 | 1 | 0 |
| NIOSH World Trade Center Health Program | 25.8 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 25.8 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 25.8 | 1 | 0 |
| Jefferson Health | 25.8 | 1 | 0 |
| Fred R. Volkmar | 25.8 | 1 | 0 |
| Yale Journal of Biology and Medicine | 25.8 | 1 | 0 |
| Online Journal of Nursing Informatics | 25.8 | 1 | 0 |
| Mohamed Mansour | 25.8 | 1 | 0 |
| Verily Life Sciences | 25.8 | 1 | 0 |
| Marion Veterans Affairs Medical Center | 25.8 | 1 | 0 |
| National Death Index | 25.8 | 1 | 0 |
| Immanuel St. Joseph's | 25.8 | 1 | 0 |
| Healthline | 25.8 | 1 | 0 |
| National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention | 25.8 | 1 | 0 |
| Suburban Hospital | 25.8 | 1 | 0 |
| National Center for Immunization and Respiratory Diseases | 25.8 | 1 | 0 |
| Edward Thomas Ryan | 25.8 | 1 | 0 |
| NIOSH pocket guide to chemical hazards (superseded) | 25.8 | 1 | 0 |
| Teladoc | 25.8 | 1 | 0 |
| Godfrey D. Pearlson | 25.8 | 1 | 0 |
| William G. Nelson | 25.8 | 1 | 0 |
| Charles Limb | 25.8 | 1 | 0 |
| Joseph John Klimek | 25.8 | 1 | 0 |
| National Violent Death Reporting System | 25.8 | 1 | 0 |
| Sonja A. Rasmussen | 25.8 | 1 | 0 |
| Mayo Clinic Graduate School of Biomedical Sciences | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| Jiansong Xu | 25.8 | 1 | 0 |
| Patrick D. Worhunsky | 25.8 | 1 | 0 |
| Sheng Zhang | 25.8 | 1 | 0 |
| Michael Stevens | 25.8 | 1 | 0 |
| Monthly vital statistics report : provisional statistics from the National Center for Health Statistics | 25.8 | 1 | 0 |
| The Permanente Journal | 25.8 | 1 | 0 |
| Advance data | 25.8 | 1 | 0 |
| Vital and health statistics. Series 10, Data from the National Health Survey | 25.8 | 1 | 0 |
| Vital and health statistics. Series 11, Data from the national health survey | 25.8 | 1 | 0 |
| Vital and health statistics. Series 21, Data from the National Vital Statistics System | 25.8 | 1 | 0 |
| Vital and health statistics. Series 23, Data from the National Survey of Family Growth | 25.8 | 1 | 0 |
| Vital and health statistics. Series 20, Data from the National Vital Statistics System | 25.8 | 1 | 0 |
| FDA medical bulletin : important information for health professionals from the U.S. Food & Drug Administration | 25.8 | 1 | 0 |
| National health statistics reports | 25.8 | 1 | 0 |
| major depressive disorder | 17.2 | 0 | 1 |
| Rotterdam Convention | 17.2 | 0 | 1 |
| disk encryption | 17.2 | 0 | 1 |
| anorexia nervosa | 17.2 | 0 | 1 |
| information security | 17.2 | 0 | 1 |
| medical director | 17.2 | 0 | 1 |
| bariatric surgery | 17.2 | 0 | 1 |
| hyperemesis gravidarum | 17.2 | 0 | 1 |
| glucagon-like peptide-1 | 17.2 | 0 | 1 |
| emaciation | 17.2 | 0 | 1 |
| Simple Authentication and Security Layer | 17.2 | 0 | 1 |
| weight loss | 17.2 | 0 | 1 |
| informed consent | 17.2 | 0 | 1 |
| exclusion criteria for blood donation | 17.2 | 0 | 1 |
| reducing diet | 17.2 | 0 | 1 |
| data security | 17.2 | 0 | 1 |
| weight cycling | 17.2 | 0 | 1 |
| Q1259954 | 17.2 | 0 | 1 |
| William Banting | 17.2 | 0 | 1 |
| bariatric medicine | 17.2 | 0 | 1 |
| Gesellschaft für Datenschutz und Datensicherheit | 17.2 | 0 | 1 |
| low-glycemic diet | 17.2 | 0 | 1 |
| Cabbage soup diet | 17.2 | 0 | 1 |
| The China Study | 17.2 | 0 | 1 |
| RSA | 17.2 | 0 | 1 |
| Payment Card Industry Data Security Standard | 17.2 | 0 | 1 |
| healthy weight loss | 17.2 | 0 | 1 |
| midwifery-led continuity of care | 17.2 | 0 | 1 |
| means test | 17.2 | 0 | 1 |
| vulnerable population | 17.2 | 0 | 1 |
| Scarsdale diet | 17.2 | 0 | 1 |
| OneSpan | 17.2 | 0 | 1 |
| Valérie Orsoni | 17.2 | 0 | 1 |
| stress echocardiography | 17.2 | 0 | 1 |
| Extreme Weight Loss | 17.2 | 0 | 1 |
| ileitis | 17.2 | 0 | 1 |
| Continuity of Care Document | 17.2 | 0 | 1 |
| GFI Software | 17.2 | 0 | 1 |
| Dosing | 17.2 | 0 | 1 |
| weight loss product | 17.2 | 0 | 1 |
| Ameridose | 17.2 | 0 | 1 |
| Anti Obesity Day | 17.2 | 0 | 1 |
| Austen Riggs Center | 17.2 | 0 | 1 |
| Basic metabolic panel | 17.2 | 0 | 1 |
| California Contractors State License Board | 17.2 | 0 | 1 |
| CalorieKing | 17.2 | 0 | 1 |
| Cigarette smoking for weight loss | 17.2 | 0 | 1 |
| comprehensive metabolic panel | 17.2 | 0 | 1 |
| consent | 17.2 | 0 | 1 |
| Continuity of Care Record | 17.2 | 0 | 1 |
| Credant Technologies | 17.2 | 0 | 1 |
| Data Security Council of India | 17.2 | 0 | 1 |
| Diane Kress | 17.2 | 0 | 1 |
| Eva Orsmond | 17.2 | 0 | 1 |
| Eskatrol | 17.2 | 0 | 1 |
| GSK716155 | 17.2 | 0 | 1 |
| glucagon-like peptide-1 agonist | 17.2 | 0 | 1 |
| Hard keeper | 17.2 | 0 | 1 |
| Herbal Magic | 17.2 | 0 | 1 |
| Cuestión de peso | 17.2 | 0 | 1 |
| ileocolitis | 17.2 | 0 | 1 |
| cachexia | 17.2 | 0 | 1 |
| Imperva | 17.2 | 0 | 1 |
| Informed Consent | 17.2 | 0 | 1 |
| Naturhouse | 17.2 | 0 | 1 |
| involuntary euthanasia | 17.2 | 0 | 1 |
| James Caird Burt | 17.2 | 0 | 1 |
| Category:Data security | 17.2 | 0 | 1 |
| Loss of United Kingdom child benefit data | 17.2 | 0 | 1 |
| Luther Lochman von Wedekind | 17.2 | 0 | 1 |
| Medical Director of the Year Award | 17.2 | 0 | 1 |
| Metabolic panel | 17.2 | 0 | 1 |
| My Weight Loss Coach | 17.2 | 0 | 1 |
| NIST Special Publication 800-37 | 17.2 | 0 | 1 |
| National Clinical Guideline Centre | 17.2 | 0 | 1 |
| National Weight Control Registry | 17.2 | 0 | 1 |
| Nutrisystem | 17.2 | 0 | 1 |
| Category:Weight loss | 17.2 | 0 | 1 |
| Online weight loss plans | 17.2 | 0 | 1 |
| PEERtrainer | 17.2 | 0 | 1 |
| Prey | 17.2 | 0 | 1 |
| primary nursing | 17.2 | 0 | 1 |
| Revision weight loss surgery | 17.2 | 0 | 1 |
| Roger Sanders | 17.2 | 0 | 1 |
| Skinny Bitch | 17.2 | 0 | 1 |
| Slimming World | 17.2 | 0 | 1 |
| System of concepts to support continuity of care | 17.2 | 0 | 1 |
| Texas Medical Board | 17.2 | 0 | 1 |
| The Weight-Loss Cure "They" Don't Want You to Know About | 17.2 | 0 | 1 |
| Trim and Fit | 17.2 | 0 | 1 |
| Weight Loss | 17.2 | 0 | 1 |
| Weight Loss | 17.2 | 0 | 1 |
| Weight Wins | 17.2 | 0 | 1 |
| weight cutting | 17.2 | 0 | 1 |
| Weight loss coaching | 17.2 | 0 | 1 |
| Weight loss effects of water | 17.2 | 0 | 1 |
| Wellspring camps | 17.2 | 0 | 1 |
| inclusion criterion | 17.2 | 0 | 1 |
| Japan Card Data Security Consortium | 17.2 | 0 | 1 |
| registered dietitian | 17.2 | 0 | 1 |
| Computer Security Day | 17.2 | 0 | 1 |
| Category:Weight loss companies | 17.2 | 0 | 1 |
| New England Compounding Center | 17.2 | 0 | 1 |
| Clinical Evidence | 17.2 | 0 | 1 |
| Asian Nursing Research | 17.2 | 0 | 1 |
| J. D. Sheffield | 17.2 | 0 | 1 |
| Charles D'Angelo | 17.2 | 0 | 1 |
| Henry Gustav Beyer | 17.2 | 0 | 1 |
| Eat to Live | 17.2 | 0 | 1 |
| Weight loss | 17.2 | 0 | 1 |
| means-tested benefit | 17.2 | 0 | 1 |
| Free, prior and informed consent | 17.2 | 0 | 1 |
| Health Management Resources | 17.2 | 0 | 1 |
| Retrofit | 17.2 | 0 | 1 |
| tokenization | 17.2 | 0 | 1 |
| weight management | 17.2 | 0 | 1 |
| In re Zappos.com, Inc., Customer Data Security Breach Litigation | 17.2 | 0 | 1 |
| Oregon Medical Board | 17.2 | 0 | 1 |
| PARAMOUNT trial | 17.2 | 0 | 1 |
| Martin Elliott | 17.2 | 0 | 1 |
| Wikidata:Notability/Exclusion criteria | 17.2 | 0 | 1 |
| Wtlr1 | 17.2 | 0 | 1 |
| Wtlr2 | 17.2 | 0 | 1 |
| Wtlr3 | 17.2 | 0 | 1 |
| Wtlr4 | 17.2 | 0 | 1 |
| typhoidal tularemia | 17.2 | 0 | 1 |
| gastroduodenal Crohn's disease | 17.2 | 0 | 1 |
| lung carcinoma | 17.2 | 0 | 1 |
| PARAMOUNT Eli Lilly Informed Consent Document | 17.2 | 0 | 1 |
| Faculty of Medical Leadership and Management | 17.2 | 0 | 1 |
| William Bevan Lewis | 17.2 | 0 | 1 |
| The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome | 17.2 | 0 | 1 |
| Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved | 17.2 | 0 | 1 |
| Using Clinical Evidence in a national continuing medical education program in Italy | 17.2 | 0 | 1 |
| Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men | 17.2 | 0 | 1 |
| High-Protein Weight Loss Diets and Purported Adverse Effects: Where is the Evidence? | 17.2 | 0 | 1 |
| Management of the infertile couple: an evidence-based protocol | 17.2 | 0 | 1 |
| PET probe-guided surgery: applications and clinical protocol | 17.2 | 0 | 1 |
| Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group | 17.2 | 0 | 1 |
| Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report | 17.2 | 0 | 1 |
| Emphasising Personal Investment Effects Weight Loss and Hedonic Thoughts about Food after Obesity Surgery | 17.2 | 0 | 1 |
| The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials | 17.2 | 0 | 1 |
| The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials | 17.2 | 0 | 1 |
| Secure Islands | 17.2 | 0 | 1 |
| Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study | 17.2 | 0 | 1 |
| Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss | 17.2 | 0 | 1 |
| medical supervision of athletes | 17.2 | 0 | 1 |
| Victor Heiser | 17.2 | 0 | 1 |
| Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians | 17.2 | 0 | 1 |
| Diet in the management of weight loss | 17.2 | 0 | 1 |
| Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss | 17.2 | 0 | 1 |
| Cognitive-Behavioral Therapy for Weight Management and Eating Disorders in Children and Adolescents | 17.2 | 0 | 1 |
| Female genital mutilation and infections: a systematic review of the clinical evidence | 17.2 | 0 | 1 |
| Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians | 17.2 | 0 | 1 |
| Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians | 17.2 | 0 | 1 |
| Physiotherapy clinical guidelines for Huntington’s disease | 17.2 | 0 | 1 |
| An approach to the management of unintentional weight loss in elderly people | 17.2 | 0 | 1 |
| Obesity medicine | 17.2 | 0 | 1 |
| Workplace-Based Participatory Approach to Weight Loss for Correctional Employees | 17.2 | 0 | 1 |
| Steps to health employee weight management randomized control trial: short-term follow-up results | 17.2 | 0 | 1 |
| excess skin | 17.2 | 0 | 1 |
| A clinical trial on weight loss among truck drivers | 17.2 | 0 | 1 |
| Clinical guidelines for occupational lifting in pregnancy: evidence summary and provisional recommendations | 17.2 | 0 | 1 |
| The steps to health employee weight management randomized control trial: rationale, design and baseline characteristics | 17.2 | 0 | 1 |
| Body weight management in overweight and obese breast cancer survivors | 17.2 | 0 | 1 |
| Psychosocial interventions for the maintenance of weight loss in obese adults | 17.2 | 0 | 1 |
| Commercial weight loss products and services for obese and overweight adults | 17.2 | 0 | 1 |
| Surgery for weight loss in adults | 17.2 | 0 | 1 |
| Audio-visual presentation of information for informed consent for participation in clinical trials | 17.2 | 0 | 1 |
| Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors | 17.2 | 0 | 1 |
| Chinese herbal medicines for weight loss | 17.2 | 0 | 1 |
| Extended discussion of information for informed consent for participation in clinical trials | 17.2 | 0 | 1 |
| Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults | 17.2 | 0 | 1 |
| Interventions to promote informed consent for patients undergoing surgical and other invasive healthcare procedures | 17.2 | 0 | 1 |
| Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people | 17.2 | 0 | 1 |
| Weight loss interventions for chronic asthma | 17.2 | 0 | 1 |
| Interventions to improve continuity of care in the follow-up of patients with cancer | 17.2 | 0 | 1 |
| Commercial weight loss products and services for obese and overweight adults | 17.2 | 0 | 1 |
| Green tea for weight loss and weight maintenance in overweight or obese adults | 17.2 | 0 | 1 |
| Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults | 17.2 | 0 | 1 |
| Interventions for fatigue and weight loss in adults with advanced progressive illness | 17.2 | 0 | 1 |
| Weight loss interventions for chronic asthma | 17.2 | 0 | 1 |
| The use of Cochrane Reviews in NICE clinical guidelines | 17.2 | 0 | 1 |
| Interventions to promote informed consent for patients undergoing surgical and other invasive healthcare procedures | 17.2 | 0 | 1 |
| Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults | 17.2 | 0 | 1 |
| Green tea for weight loss and weight maintenance in overweight or obese adults | 17.2 | 0 | 1 |
| Interventions for fatigue and weight loss in adults with advanced progressive illness | 17.2 | 0 | 1 |
| Interventions to improve continuity of care in the follow-up of patients with cancer | 17.2 | 0 | 1 |
| Computer-based interventions for weight loss or weight maintenance in overweight or obese people | 17.2 | 0 | 1 |
| Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults | 17.2 | 0 | 1 |
| Audio-visual presentation of information for informed consent for participation in clinical trials | 17.2 | 0 | 1 |
| Chinese herbal medicines for weight loss | 17.2 | 0 | 1 |
| Psychosocial interventions for the maintenance of weight loss in obese adults | 17.2 | 0 | 1 |
| Weight loss for primary prevention of stroke in people with overweight or obesity | 17.2 | 0 | 1 |
| Long-term non-pharmacological weight loss interventions for adults with prediabetes | 17.2 | 0 | 1 |
| Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus | 17.2 | 0 | 1 |
| Anabolic steroids for the treatment of weight loss in HIV-infected individuals | 17.2 | 0 | 1 |
| Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus | 17.2 | 0 | 1 |
| Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus | 17.2 | 0 | 1 |
| Addressing tensions when popular media and evidence-based care collide | 17.2 | 0 | 1 |
| The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease | 17.2 | 0 | 1 |
| Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet‐induced obesity | 17.2 | 0 | 1 |
| The Use of Nonprescription Weight Loss Products Among Female Basketball, Softball, and Volleyball Athletes from NCAA Division I Institutions: Issues and Concerns. | 17.2 | 0 | 1 |
| Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits | 17.2 | 0 | 1 |
| Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review | 17.2 | 0 | 1 |
| Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods | 17.2 | 0 | 1 |
| Informed consent in the genomics era | 17.2 | 0 | 1 |
| The clinical document architecture and the continuity of care record: a critical analysis | 17.2 | 0 | 1 |
| Thermodynamics of weight loss diets | 17.2 | 0 | 1 |
| Legal considerations of clinical guidelines: will NICE make a difference? | 17.2 | 0 | 1 |
| Liposuction does not achieve metabolic benefits of weight loss | 17.2 | 0 | 1 |
| Desmopressin in the treatment of nocturia: clinical evidence and experience | 17.2 | 0 | 1 |
| Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence | 17.2 | 0 | 1 |
| Weight loss to treat urinary incontinence in overweight and obese women | 17.2 | 0 | 1 |
| Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil | 17.2 | 0 | 1 |
| Hydroxycut(®) (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature | 17.2 | 0 | 1 |
| Grapefruit-medication interactions: forbidden fruit or avoidable consequences? | 17.2 | 0 | 1 |
| Beverage consumption and adult weight management: A review | 17.2 | 0 | 1 |
| The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control | 17.2 | 0 | 1 |
| Science of weight loss supplements: Compromised by conflicts of interest? | 17.2 | 0 | 1 |
| European clinical guidelines for Tourette Syndrome and other tic disorders | 17.2 | 0 | 1 |
| Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial | 17.2 | 0 | 1 |
| Water consumption increases weight loss during a hypocaloric diet intervention in middle-aged and older adults | 17.2 | 0 | 1 |
| 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study | 17.2 | 0 | 1 |
| Eyes Wide Open: The Personal Genome Project, Citizen Science and Veracity in Informed Consent | 17.2 | 0 | 1 |
| Effect of exercise on 24-month weight loss maintenance in overweight women | 17.2 | 0 | 1 |
| Follow-up of patients with curatively resected colorectal cancer: a practice guideline | 17.2 | 0 | 1 |
| The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study | 17.2 | 0 | 1 |
| Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquine | 17.2 | 0 | 1 |
| Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans | 17.2 | 0 | 1 |
| Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements | 17.2 | 0 | 1 |
| Weight loss during the intensive intervention phase of the weight-loss maintenance trial | 17.2 | 0 | 1 |
| Risks and benefits of commonly used herbal medicines in Mexico | 17.2 | 0 | 1 |
| Realistic expectations of prepulse inhibition in translational models for schizophrenia research | 17.2 | 0 | 1 |
| The effects of exercise and weight loss in overweight patients with hip osteoarthritis: design of a prospective cohort study | 17.2 | 0 | 1 |
| Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation | 17.2 | 0 | 1 |
| Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence | 17.2 | 0 | 1 |
| Clinical evidence of blood transfusion effectiveness | 17.2 | 0 | 1 |
| Revisiting leptin's role in obesity and weight loss | 17.2 | 0 | 1 |
| Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery | 17.2 | 0 | 1 |
| Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing | 17.2 | 0 | 1 |
| Continuity of care: a multidisciplinary review | 17.2 | 0 | 1 |
| Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss | 17.2 | 0 | 1 |
| Quality assessment of patient leaflets on misoprostol-induced labour: does written information adhere to international standards for patient involvement and informed consent? | 17.2 | 0 | 1 |
| Separation of risks and benefits of seafood intake | 17.2 | 0 | 1 |
| Explanations for weight loss after ileojejunal bypass in gross obesity | 17.2 | 0 | 1 |
| BRIEF REPORT: nutrition and weight loss information in a popular diet book: is it fact, fiction, or something in between? | 17.2 | 0 | 1 |
| Chiropractic clinical practice guideline: evidence-based treatment of adult neck pain not due to whiplash | 17.2 | 0 | 1 |
| Informed consent | 17.2 | 0 | 1 |
| Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats | 17.2 | 0 | 1 |
| A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion | 17.2 | 0 | 1 |
| Informed consent in embryonic stem cell research: are we following basic principles? | 17.2 | 0 | 1 |
| Risks and benefits of azathioprine therapy | 17.2 | 0 | 1 |
| Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment | 17.2 | 0 | 1 |
| The student and the ovum: the lack of autonomy and informed consent in trading genes for tuition | 17.2 | 0 | 1 |
| Weight loss dynamics during combined fluoxetine and olanzapine treatment | 17.2 | 0 | 1 |
| Informed consent and research design in critical care medicine | 17.2 | 0 | 1 |
| Clinical Evidence: a useful tool for promoting evidence-based practice? | 17.2 | 0 | 1 |
| Preventive medical care in remote Aboriginal communities in the Northern Territory: a follow-up study of the impact of clinical guidelines, computerised recall and reminder systems, and audit and feedback | 17.2 | 0 | 1 |
| Diet and physical activity behavior among users of prescription weight loss medications | 17.2 | 0 | 1 |
| Clinical practice guideline on the optimal radiotherapeutic management of brain metastases | 17.2 | 0 | 1 |
| Results of soy-based meal replacement formula on weight, anthropometry, serum lipids & blood pressure during a 40-week clinical weight loss trial | 17.2 | 0 | 1 |
| Optimizing the HIV/AIDS informed consent process in India | 17.2 | 0 | 1 |
| Who will lose weight? A reexamination of predictors of weight loss in women | 17.2 | 0 | 1 |
| Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline | 17.2 | 0 | 1 |
| Attitudes of the Japanese public and doctors towards use of archived information and samples without informed consent: preliminary findings based on focus group interviews | 17.2 | 0 | 1 |
| Reporting quality of randomized trials in the diet and exercise literature for weight loss | 17.2 | 0 | 1 |
| Comparative Hepatology: A journal for all hepatologists with immediate Open Access to quality peer-reviewed research | 17.2 | 0 | 1 |
| Weight loss maintenance in women two to eleven years after participating in a commercial program: a survey | 17.2 | 0 | 1 |
| Being uninformed on informed consent: a pilot survey of medical education faculty | 17.2 | 0 | 1 |
| Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women | 17.2 | 0 | 1 |
| A 61-year-old man with dyspepsia and weight loss | 17.2 | 0 | 1 |
| Weight loss and mortality: what does the evidence show? | 17.2 | 0 | 1 |
| Weight Loss and Mortality | 17.2 | 0 | 1 |
| Follow-up care by patient's own general practitioner after contact with out-of-hours care. A descriptive study | 17.2 | 0 | 1 |
| Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats | 17.2 | 0 | 1 |
| Diet induced weight loss accelerates onset of negative alliesthesia in obese women | 17.2 | 0 | 1 |
| Clinical guidelines for adults exposed to World Trade Center disaster | 17.2 | 0 | 1 |
| Continued process verification | 17.2 | 0 | 1 |
| The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial | 17.2 | 0 | 1 |
| Fellow of the Zoological Society of London | 17.2 | 0 | 1 |
| Data security for in-mine transmission. Final report - part 1 | 17.2 | 0 | 1 |
| Data security for in-mine transmission. Final report--part II | 17.2 | 0 | 1 |
| Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults | 17.2 | 0 | 1 |
| Drinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gain | 17.2 | 0 | 1 |
| Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors | 17.2 | 0 | 1 |
| User involvement in the implementation of clinical guidelines for common mental health disorders: a review and compilation of strategies and resources | 17.2 | 0 | 1 |
| Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System | 17.2 | 0 | 1 |
| Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence | 17.2 | 0 | 1 |
| Prolactin-releasing peptide: a new tool for obesity treatment | 17.2 | 0 | 1 |
| Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectives | 17.2 | 0 | 1 |
| Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss | 17.2 | 0 | 1 |
| Increased Hydration Can Be Associated with Weight Loss | 17.2 | 0 | 1 |
| Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence | 17.2 | 0 | 1 |
| Rethinking Intelligence Quotient Exclusion Criteria Practices in the Study of Attention Deficit Hyperactivity Disorder | 17.2 | 0 | 1 |
| Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives | 17.2 | 0 | 1 |
| Current status of intragastric balloon for obesity treatment | 17.2 | 0 | 1 |
| Diet Versus Exercise in Weight Loss and Maintenance: Focus on Tryptophan | 17.2 | 0 | 1 |
| Brachial-Ankle Pulse Wave Velocity: Background, Method, and Clinical Evidence | 17.2 | 0 | 1 |
| Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience | 17.2 | 0 | 1 |
| Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical Evidence | 17.2 | 0 | 1 |
| Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals | 17.2 | 0 | 1 |
| An Analysis of Behaviour Change Techniques Used in a Sample of Gestational Weight Management Trials | 17.2 | 0 | 1 |
| Weight change among people randomized to minimal intervention control groups in weight loss trials | 17.2 | 0 | 1 |
| "Negotiorum Gestio" in Family Medicine, Informed Consent Obtainment, and Disciplinary Responsibility | 17.2 | 0 | 1 |
| In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins | 17.2 | 0 | 1 |
| The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections | 17.2 | 0 | 1 |
| Long-term weight loss maintenance for obesity: a multidisciplinary approach | 17.2 | 0 | 1 |
| Level of clinical evidence presented at the International Society for Hip Arthroscopy Annual Scientific Meeting over 5 years (2010-2014) | 17.2 | 0 | 1 |
| Fingolimod in the treatment of relapsing–remitting multiple sclerosis: long-term experience and an update on the clinical evidence | 17.2 | 0 | 1 |
| A clinical perspective of obesity, metabolic syndrome and cardiovascular disease | 17.2 | 0 | 1 |
| A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus | 17.2 | 0 | 1 |
| Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS | 17.2 | 0 | 1 |
| Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits | 17.2 | 0 | 1 |
| The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence | 17.2 | 0 | 1 |
| Interdependence of nutrient metabolism and the circadian clock system: Importance for metabolic health | 17.2 | 0 | 1 |
| The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity | 17.2 | 0 | 1 |
| Clinical guidelines for Western clinicians engaged in primary care medical service trips in Latin America and the Caribbean: an integrative literature review | 17.2 | 0 | 1 |
| A review and content analysis of engagement, functionality, aesthetics, information quality, and change techniques in the most popular commercial apps for weight management | 17.2 | 0 | 1 |
| Early versus late tracheostomy for critically ill patients: A clinical evidence synopsis of a recent Cochrane Review | 17.2 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 17.2 | 0 | 1 |
| Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence | 17.2 | 0 | 1 |
| Central retinal vein occlusion: A review of current Evidence-based treatment options | 17.2 | 0 | 1 |
| Data security in genomics: A review of Australian privacy requirements and their relation to cryptography in data storage | 17.2 | 0 | 1 |
| Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence | 17.2 | 0 | 1 |
| Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis | 17.2 | 0 | 1 |
| Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective | 17.2 | 0 | 1 |
| Thrombus aspiration during primary percutaneous coronary intervention for acute myocardial infarction: A review of clinical evidence and guidelines | 17.2 | 0 | 1 |
| Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use | 17.2 | 0 | 1 |
| Optimal delivery of male breast cancer follow-up care: improving outcomes | 17.2 | 0 | 1 |
| Impact of obesity treatment on gastroesophageal reflux disease | 17.2 | 0 | 1 |
| Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials | 17.2 | 0 | 1 |
| Pancreas Islet Transplantation for Patients With Type 1 Diabetes Mellitus: A Clinical Evidence Review | 17.2 | 0 | 1 |
| NIH working group report-using genomic information to guide weight management: From universal to precision treatment | 17.2 | 0 | 1 |
| Weight management in obesity – past and present | 17.2 | 0 | 1 |
| Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks | 17.2 | 0 | 1 |
| Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss | 17.2 | 0 | 1 |
| Cognitive Remediation Therapy for Brain Tumor Survivors with Cognitive Deficits | 17.2 | 0 | 1 |
| Motivational Interviewing in Childhood Obesity Treatment | 17.2 | 0 | 1 |
| Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials | 17.2 | 0 | 1 |
| Clinical guidelines for the use of intraoperative fluorescence diagnosis in brain tumor surgery | 17.2 | 0 | 1 |
| Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence | 17.2 | 0 | 1 |
| Effectiveness of implementation strategies for clinical guidelines to community pharmacy: a systematic review | 17.2 | 0 | 1 |
| Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments | 17.2 | 0 | 1 |
| Mobile Phone Apps to Promote Weight Loss and Increase Physical Activity: A Systematic Review and Meta-Analysis | 17.2 | 0 | 1 |
| Weight Management for Athletes and Active Individuals: A Brief Review | 17.2 | 0 | 1 |
| Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey | 17.2 | 0 | 1 |
| Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors | 17.2 | 0 | 1 |
| Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria | 17.2 | 0 | 1 |
| Clinical guidelines on intraoperative neuromonitoring during thyroid and parathyroid surgery | 17.2 | 0 | 1 |
| Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications | 17.2 | 0 | 1 |
| The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol | 17.2 | 0 | 1 |
| Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis | 17.2 | 0 | 1 |
| Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review | 17.2 | 0 | 1 |
| Egg Consumption and Human Cardio-Metabolic Health in People with and without Diabetes | 17.2 | 0 | 1 |
| The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans | 17.2 | 0 | 1 |
| Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review | 17.2 | 0 | 1 |
| The role of genes involved in lipolysis on weight loss program in overweight and obese individuals | 17.2 | 0 | 1 |
| You Lose Some, You Win Some: Weight Loss Induces Microbiota and Metabolite Shifts | 17.2 | 0 | 1 |
| Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols | 17.2 | 0 | 1 |
| FGF21, energy expenditure and weight loss – How much brown fat do you need? | 17.2 | 0 | 1 |
| The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups | 17.2 | 0 | 1 |
| Effect of non-surgical, non-pharmacological weight loss interventions in patients who are obese prior to hip and knee arthroplasty surgery: a rapid review | 17.2 | 0 | 1 |
| Is consuming yoghurt associated with weight management outcomes? Results from a systematic review | 17.2 | 0 | 1 |
| Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case series | 17.2 | 0 | 1 |
| Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence | 17.2 | 0 | 1 |
| Longitudinal omics modeling and integration in clinical metabonomics research: challenges in childhood metabolic health research | 17.2 | 0 | 1 |
| Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer | 17.2 | 0 | 1 |
| Assessment and Management of Delirium in Older Adults in the Emergency Department: Literature Review to Inform Development of a Novel Clinical Protocol | 17.2 | 0 | 1 |
| Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration | 17.2 | 0 | 1 |
| Adipose-Derived Mesenchymal Stem Cells for the Treatment of Articular Cartilage: A Systematic Review on Preclinical and Clinical Evidence | 17.2 | 0 | 1 |
| Review of the powder and decoction formulae in Traditional Chinese Medicine based on pharmacologically active substances and clinical evidence | 17.2 | 0 | 1 |
| Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence | 17.2 | 0 | 1 |
| Informed consent in clinical research: Consensus recommendations for reform identified by an expert interview panel | 17.2 | 0 | 1 |
| A Review of Nebivolol Pharmacology and Clinical Evidence | 17.2 | 0 | 1 |
| Weight Loss Instead of Weight Gain within the Guidelines in Obese Women during Pregnancy: A Systematic Review and Meta-Analyses of Maternal and Infant Outcomes | 17.2 | 0 | 1 |
| Minimally invasive emergent techniques in obesity treatment | 17.2 | 0 | 1 |
| 'Small changes' to diet and physical activity behaviors for weight management | 17.2 | 0 | 1 |
| Confronting diversity in the production of clinical evidence goes beyond merely including under-represented groups in clinical trials | 17.2 | 0 | 1 |
| Risks and benefits of citrate anticoagulation for continuous renal replacement therapy | 17.2 | 0 | 1 |
| GLP-1 receptor agonists: a review of head-to-head clinical studies | 17.2 | 0 | 1 |
| Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium | 17.2 | 0 | 1 |
| Fertility preservation during cancer treatment: clinical guidelines | 17.2 | 0 | 1 |
| The Evolution of Honest Communication: Integrating Social and Physiological Costs of Ornamentation | 17.2 | 0 | 1 |
| Weight loss and bone mineral density | 17.2 | 0 | 1 |
| Infection prevention and the medical director: uncharted territory | 17.2 | 0 | 1 |
| Aspects of vulnerable patients and informed consent in clinical trials | 17.2 | 0 | 1 |
| Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms | 17.2 | 0 | 1 |
| Do We Have a Workable Clinical Protocol for Differentiating Lympho‐Hematopoietic Stem Cells from the Source of Embryonic Stem Cells and Induced Pluripotent Stem Cells in Culture? | 17.2 | 0 | 1 |
| Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health | 17.2 | 0 | 1 |
| Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Brain responses to food and weight loss | 17.2 | 0 | 1 |
| Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials | 17.2 | 0 | 1 |
| Weight loss maintenance: A review on dietary related strategies | 17.2 | 0 | 1 |
| Ticagrelor: molecular discovery to clinical evidence: ticagrelor: a novel antiplatelet agent | 17.2 | 0 | 1 |
| Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application | 17.2 | 0 | 1 |
| N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence | 17.2 | 0 | 1 |
| Weight loss in children and adolescents | 17.2 | 0 | 1 |
| Arm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelines | 17.2 | 0 | 1 |
| Different aspects of informed consent in aesthetic surgeries | 17.2 | 0 | 1 |
| The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence | 17.2 | 0 | 1 |
| Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses | 17.2 | 0 | 1 |
| Informed consent process for patient participation in rare disease registries linked to biorepositories | 17.2 | 0 | 1 |
| Vascular disturbances in primary aldosteronism: clinical evidence | 17.2 | 0 | 1 |
| Evidence-based treatment strategies in idiopathic pulmonary fibrosis | 17.2 | 0 | 1 |
| Improving informed consent in percutaneous coronary revascularisation | 17.2 | 0 | 1 |
| Translational research into gut microbiota: new horizons on obesity treatment: updated 2014 | 17.2 | 0 | 1 |
| THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues | 17.2 | 0 | 1 |
| Dairy Foods and Dairy Proteins in the Management of Type 2 Diabetes: A Systematic Review of the Clinical Evidence | 17.2 | 0 | 1 |
| Clinical guidelines for late-onset Pompe disease | 17.2 | 0 | 1 |
| Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Effectiveness of Weight Loss Interventions for Obese Older Adults | 17.2 | 0 | 1 |
| Deep venous thrombosis in children with musculoskeletal infections: the clinical evidence | 17.2 | 0 | 1 |
| Mechanisms of Weight Regain following Weight Loss | 17.2 | 0 | 1 |
| Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage | 17.2 | 0 | 1 |
| The downside of weight loss: realistic intervention in body-weight trajectory | 17.2 | 0 | 1 |
| Continuity of medication management and continuity of care: Conceptual and operational considerations | 17.2 | 0 | 1 |
| Hematopoietic growth factors: personalization of risks and benefits | 17.2 | 0 | 1 |
| Moonshot Science-Risks and Benefits | 17.2 | 0 | 1 |
| Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery | 17.2 | 0 | 1 |
| Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transport | 17.2 | 0 | 1 |
| Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits | 17.2 | 0 | 1 |
| Determinants of shortened, disrupted, and mistimed sleep and associated metabolic health consequences in healthy humans | 17.2 | 0 | 1 |
| The effect of physical activity on weight loss | 17.2 | 0 | 1 |
| Self‐transfer and mortality amongst adults lost to follow‐up in ART programmes in low‐ and middle‐income countries: systematic review and meta‐analysis | 17.2 | 0 | 1 |
| Self-directed interventions to promote weight loss: a systematic review of reviews | 17.2 | 0 | 1 |
| Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer | 17.2 | 0 | 1 |
| Clinical prediction rules in practice: review of clinical guidelines and survey of GPs | 17.2 | 0 | 1 |
| Long-term breast cancer patient follow-up care | 17.2 | 0 | 1 |
| Psychological benefits of weight loss following behavioural and/or dietary weight loss interventions. A systematic research review | 17.2 | 0 | 1 |
| Measuring Outcomes in Adult Weight Loss Studies That Include Diet and Physical Activity: A Systematic Review | 17.2 | 0 | 1 |
| Cure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidence | 17.2 | 0 | 1 |
| In search of evidence-based treatment for concussion: characteristics of current clinical trials | 17.2 | 0 | 1 |
| Community pharmacy interventions for public health priorities: protocol for a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions | 17.2 | 0 | 1 |
| Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence | 17.2 | 0 | 1 |
| Lixisenatide as add-on therapy to basal insulin | 17.2 | 0 | 1 |
| Weight loss and African-American women: a systematic review of the behavioural weight loss intervention literature | 17.2 | 0 | 1 |
| Weight loss in obese adults 65years and older: A review of the controversy | 17.2 | 0 | 1 |
| Is Informed Consent Broken? | 17.2 | 0 | 1 |
| Informed consent comprehension in African research settings | 17.2 | 0 | 1 |
| Obesity and weight loss could alter the properties of adipose stem cells? | 17.2 | 0 | 1 |
| Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis | 17.2 | 0 | 1 |
| Periconception weight loss: common sense for mothers, but what about for babies? | 17.2 | 0 | 1 |
| Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis | 17.2 | 0 | 1 |
| Body Image Change in Obese and Overweight Persons Enrolled in Weight Loss Intervention Programs: A Systematic Review and Meta-Analysis | 17.2 | 0 | 1 |
| Myelodysplastic syndromes: the challenge of developing clinical guidelines and supportive care strategies for a rare disease | 17.2 | 0 | 1 |
| Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials | 17.2 | 0 | 1 |
| Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials | 17.2 | 0 | 1 |
| Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery | 17.2 | 0 | 1 |
| RAAS inhibition and mortality in hypertension: from pharmacology to clinical evidence | 17.2 | 0 | 1 |
| A review of the use of the 5 A's model for weight loss counselling: differences between physician practice and patient demand | 17.2 | 0 | 1 |
| Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics | 17.2 | 0 | 1 |
| Evidence-Based Care of Acute Wounds: A Perspective | 17.2 | 0 | 1 |
| Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance | 17.2 | 0 | 1 |
| To what extent do primary care practice nurses act as case managers lifestyle counselling regarding weight management? A systematic review | 17.2 | 0 | 1 |
| The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms | 17.2 | 0 | 1 |
| Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review | 17.2 | 0 | 1 |
| Genetic and epigenetic control of metabolic health | 17.2 | 0 | 1 |
| GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence | 17.2 | 0 | 1 |
| Endobronchial Valves in Treatment of Persistent Air Leaks: A Systematic Review of Clinical Evidence | 17.2 | 0 | 1 |
| Carotid revascularization: risks and benefits | 17.2 | 0 | 1 |
| Nanomaterials: Risks and Benefits | 17.2 | 0 | 1 |
| The Blue Obelisk-interoperability in chemical informatics | 17.2 | 0 | 1 |
| A survey on patients' knowledge and expectations during informed consent for spinal surgery: can we improve the shared decision-making process? | 17.2 | 0 | 1 |
| Assessing mental health clinicians' intentions to adopt evidence-based treatments: reliability and validity testing of the evidence-based treatment intentions scale | 17.2 | 0 | 1 |
| Commission of Medical Supervision at Leiden, 1856 | 17.2 | 0 | 1 |
| Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes | 17.2 | 0 | 1 |
| A survey of study participants' understanding of informed consent to participate in a randomised controlled trial of acupuncture | 17.2 | 0 | 1 |
| Improving metabolic health in obese male mice via diet and exercise restores embryo development and fetal growth | 17.2 | 0 | 1 |
| Mechanisms of change of a novel weight loss programme provided by a third sector organisation: a qualitative interview study. | 17.2 | 0 | 1 |
| Implementation of a new prenatal care model to reduce office visits and increase connectivity and continuity of care: protocol for a mixed-methods study | 17.2 | 0 | 1 |
| A Single-blinded, Randomized Clinical Trial of How to Implement an Evidence-based Treatment for Generalized Anxiety Disorder [IMPLEMENT]--Effects of Three Different Strategies of Implementation | 17.2 | 0 | 1 |
| Induction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbits | 17.2 | 0 | 1 |
| Informed consent: do information pamphlets improve post-operative risk-recall in patients undergoing total thyroidectomy: Prospective randomized control study | 17.2 | 0 | 1 |
| Examination of whether early weight loss predicts 1-year weight loss among those enrolled in an Internet-based weight loss program | 17.2 | 0 | 1 |
| Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale | 17.2 | 0 | 1 |
| Improving the informed consent process in international collaborative rare disease research: effective consent for effective research | 17.2 | 0 | 1 |
| Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI). | 17.2 | 0 | 1 |
| Working memory and processing speed training in schizophrenia: study protocol for a randomized controlled trial | 17.2 | 0 | 1 |
| Weight change in pediatric TennCare recipients referred to a commercial weight loss program | 17.2 | 0 | 1 |
| Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder.. | 17.2 | 0 | 1 |
| The weight loss blogosphere: an online survey of weight loss bloggers. | 17.2 | 0 | 1 |
| Clinical guidelines on the management of hepatitis C | 17.2 | 0 | 1 |
| Drug-induced liver injury due to “natural products” used for weight loss: A case report | 17.2 | 0 | 1 |
| Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment | 17.2 | 0 | 1 |
| Evidence Brief: Comparative Effectiveness of Appointment Recall Reminder Procedures for Follow-up Appointments | 17.2 | 0 | 1 |
| Advancing Informed Consent for Vulnerable Populations | 17.2 | 0 | 1 |
| Preoperative weight loss in bariatric surgery candidate patients. evidence-based recommendations | 17.2 | 0 | 1 |
| Current Clinical Evidence on the Effect of General Anesthesia on Neurodevelopment in Children: An Updated Systematic Review with Meta-Regression | 17.2 | 0 | 1 |
| Uniform risk-stratification and response criteria are paving the way to evidence-based treatment of AL amyloidosis | 17.2 | 0 | 1 |
| Journal of obesity & weight loss therapy | 17.2 | 0 | 1 |
| Journal of obesity and weight-loss medication | 17.2 | 0 | 1 |
| BAOJ obesity & weight loss management | 17.2 | 0 | 1 |
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | 17.2 | 0 | 1 |
| Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical Trial | 17.2 | 0 | 1 |
| The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence | 17.2 | 0 | 1 |
| The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use | 17.2 | 0 | 1 |
| The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines | 17.2 | 0 | 1 |
| Pedometer intervention and weight loss in overweight and obese adults with Type 2 diabetes: a meta-analysis | 17.2 | 0 | 1 |
| Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience | 17.2 | 0 | 1 |
| Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence? | 17.2 | 0 | 1 |
| Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence | 17.2 | 0 | 1 |
| What type of clinical evidence is needed to assess medical devices? | 17.2 | 0 | 1 |
| Safety and efficacy of fenproporex for obesity treatment: a systematic review | 17.2 | 0 | 1 |
| Natural Dietary and Herbal Products in Anti-Obesity Treatment | 17.2 | 0 | 1 |
| Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence | 17.2 | 0 | 1 |
| Alternate-day versus daily energy restriction diets: which is more effective for weight loss? A systematic review and meta-analysis | 17.2 | 0 | 1 |
| The biology and clinical evidence of microfracture in hip preservation surgery | 17.2 | 0 | 1 |
| Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject | 17.2 | 0 | 1 |
| Weight management in obese pets: the tailoring concept and how it can improve results | 17.2 | 0 | 1 |
| Changes in Energy Expenditure with Weight Gain and Weight Loss in Humans | 17.2 | 0 | 1 |
| The risks and benefits of sun exposure 2016 | 17.2 | 0 | 1 |
| A Life Course Perspective on Body Size and Cardio-metabolic Health | 17.2 | 0 | 1 |
| Hypoxia after stroke: a review of experimental and clinical evidence | 17.2 | 0 | 1 |
| Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists | 17.2 | 0 | 1 |
| Follow-up care for survivors of lymphoma who have received curative-intent treatment | 17.2 | 0 | 1 |
| Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation | 17.2 | 0 | 1 |
| A protocol to develop clinical guidelines for inclusion-body myositis | 17.2 | 0 | 1 |
| Q28078394 | 17.2 | 0 | 1 |
| Weight loss endoscopy: Development, applications, and current status | 17.2 | 0 | 1 |
| Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence | 17.2 | 0 | 1 |
| Systematic review and meta-analysis of internet-delivered interventions providing personalized feedback for weight loss in overweight and obese adults | 17.2 | 0 | 1 |
| Within and beyond the communal turn to informed consent in industry-sponsored pharmacogenetics research: merits and challenges of community advisory boards | 17.2 | 0 | 1 |
| The role for adipose tissue in weight regain after weight loss | 17.2 | 0 | 1 |
| Pandemic of Pregnant Obese Women: Is It Time to Re-Evaluate Antenatal Weight Loss? | 17.2 | 0 | 1 |
| Current and emerging medications for overweight or obesity in people with comorbidities | 17.2 | 0 | 1 |
| Barriers to primary care clinician adherence to clinical guidelines for the management of low back pain: protocol of a systematic review and meta-synthesis of qualitative studies | 17.2 | 0 | 1 |
| PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation | 17.2 | 0 | 1 |